Elvucitabine 2mg 2mg | Purity Not Available
Adooq Bioscience
Elvucitabine is an experimental nucleoside reverse transcriptase inhibitor (NRTI).
More Information Supplier PageSearch Results
Elvucitabine 1mg 1mg | Purity Not Available
Adooq Bioscience
Elvucitabine is an experimental nucleoside reverse transcriptase inhibitor (NRTI).
More Information Supplier PageGKT137831 5mg 5mg | Purity Not Available
Adooq Bioscience
GKT137831 is a first in class inhibitor targeting NOX1 and NOX4 enzymes.
More Information Supplier PageGKT137831 25mg 25mg | Purity Not Available
Adooq Bioscience
GKT137831 is a first in class inhibitor targeting NOX1 and NOX4 enzymes.
More Information Supplier PageGKT137831 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
GKT137831 is a first in class inhibitor targeting NOX1 and NOX4 enzymes.
More Information Supplier PageGKT137831 10mg 10mg | Purity Not Available
Adooq Bioscience
GKT137831 is a first in class inhibitor targeting NOX1 and NOX4 enzymes.
More Information Supplier PageGNE-493 50mg 50mg | Purity Not Available
Adooq Bioscience
GNE-493 is potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitor with potential anticancer activity.
More Information Supplier PageGNE-493 25mg 25mg | Purity Not Available
Adooq Bioscience
GNE-493 is potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitor with potential anticancer activity.
More Information Supplier PageGNE-493 10mg 10mg | Purity Not Available
Adooq Bioscience
GNE-493 is potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitor with potential anticancer activity.
More Information Supplier PageST7612AA1 5mg 5mg | Purity Not Available
Adooq Bioscience
ST7612AA1 is a new and potent HDCA inhibitor with potential anticancer activity.
More Information Supplier Page